Applied Genetic Technologies Corporation

3.80-0.1900-4.76%Vol 1.93M1Y Perf -6.63%
Apr 19th, 2021 16:00 DELAYED
BID3.73 ASK3.85
Open3.92 Previous Close3.99
Pre-Market- After-Market3.77
 - -  -0.03 -0.79%
Target Price
17.33 
Analyst Rating
Strong Buy 1.00
Potential %
356.05 
Finscreener Ranking
★★     46.71
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
     41.30
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★+     38.89
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap162.46M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
3.93 
Earnings Date
12th May 2021

Today's Price Range

3.673.94

52W Range

3.569.67

5 Year PE Ratio Range

-47.00575.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-5.24%
1 Month
-37.09%
3 Months
-18.45%
6 Months
-28.57%
1 Year
-6.63%
3 Years
-24.00%
5 Years
-76.84%
10 Years
-

TickerPriceChg.Chg.%
AGTC3.80-0.1900-4.76
AAPL134.840.68000.51
GOOG2 302.404.64000.20
MSFT258.74-2.0000-0.77
XOM56.48-0.1800-0.32
WFC43.880.04000.09
JNJ162.690.45000.28
FB302.24-3.9400-1.29
GE13.460.07000.52
JPM152.65-0.6500-0.42
Financial StrengthValueIndustryS&P 500US Markets
3.70
3.90
0.25
0.35
-83.60
Leverage Ratio 1.80
ProfitabilityValueIndustryS&P 500US Markets
-
-2 054.50
-1 997.60
-390.70
-80.91
RevenueValueIndustryS&P 500US Markets
0.00
0.00
-55.10
-29.63
Earnings HistoryEstimateReportedSurprise %
Q02 2021-0.59-0.60-1.69
Q01 2021-0.51-0.60-17.65
Q04 2020-0.46-0.56-21.74
Q03 2020-0.55-0.509.09
Q02 2020-0.59-0.4720.34
Q01 2020-0.58-0.64-10.34
Q04 2019-0.51-0.58-13.73
Q03 2019-0.540.63216.67
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.4118.00Positive
6/2021 QR-0.4114.58Positive
6/2021 FY-1.938.53Positive
6/2022 FY-1.6623.15Positive
Next Report Date12th May 2021
Estimated EPS Next Report-0.41
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume1.93M
Shares Outstanding42.75M
Trades Count12.07K
Dollar Volume16.47M
Avg. Volume2.92M
Avg. Weekly Volume1.93M
Avg. Monthly Volume1.41M
Avg. Quarterly Volume3.40M

Applied Genetic Technologies Corporation (NASDAQ: AGTC) stock closed at 3.8 per share at the end of the most recent trading day (a -4.76% change compared to the prior day closing price) with a volume of 1.94M shares and market capitalization of 162.46M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 83 people. Applied Genetic Technologies Corporation CEO is Susan B. Washer.

The one-year performance of Applied Genetic Technologies Corporation stock is -6.63%, while year-to-date (YTD) performance is -7.09%. AGTC stock has a five-year performance of -76.84%. Its 52-week range is between 3.56 and 9.67, which gives AGTC stock a 52-week price range ratio of 3.93%

Applied Genetic Technologies Corporation currently has a PE ratio of -1.80, a price-to-book (PB) ratio of 4.11, a price-to-sale (PS) ratio of 46.12, a price to cashflow ratio of 1.80, a PEG ratio of 2.32, a ROA of -70.00%, a ROC of -92.75% and a ROE of -105.78%. The company’s profit margin is -80.91%, its EBITDA margin is -1 997.60%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Applied Genetic Technologies Corporation, there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.41 for the next earnings report. Applied Genetic Technologies Corporation’s next earnings report date is 12th May 2021.

The consensus rating of Wall Street analysts for Applied Genetic Technologies Corporation is Strong Buy (1), with a target price of $17.33, which is +356.05% compared to the current price. The earnings rating for Applied Genetic Technologies Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Applied Genetic Technologies Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Applied Genetic Technologies Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 14.68, ATR14 : 0.61, CCI20 : -125.19, Chaikin Money Flow : -0.10, MACD : -0.39, Money Flow Index : 18.67, ROC : -25.05, RSI : 41.83, STOCH (14,3) : 8.14, STOCH RSI : 0.00, UO : 43.15, Williams %R : -91.86), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Applied Genetic Technologies Corporation in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (100.00 %)
6 (100.00 %)
6 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Applied Genetic Technologies Corporation

Applied Genetic Technologies Corp is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. Its initial focus is in the field of ophthalmology, where it has active clinical trials in X-linked retinitis pigmentosa, achromatopsia (ACHM CNGB3 and ACHM CNGA3), and X-linked retinoschisis. In addition to its clinical trials, company has preclinical programs in optogenetics, adrenoleukodystrophy, which is a disease of the central nervous system, other ophthalmology, and otology indications. The optogenetics program is being developed in collaboration with Bionic Sight.

CEO: Susan B. Washer

Telephone: +1 386 462-2204

Address: 14193 NW 119th Terrace, Alachua 32615, FL, US

Number of employees: 83

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

69%31%

Bearish Bullish

59%41%

Bearish Bullish

53%47%

News

Stocktwits